Skip to content
recurance

Continuing medication for VTE risk after discharge

Identical hazardConfidence 0.90 · high2 reports · 2019–2023No published response to an earlier report One-page brief (print or PDF)

National Institute for Health and Care Excellence received 2 coroners' reports about this hazard between 29 Nov 2019 and 27 Oct 2023.

They came from 2 different coroners in 2 coroner areas. A similar concern was raised again 1 time after the first warning.

No published response from National Institute for Health and Care Excellence was found for the earlier reports.

2
reports
2
different coroners
2019–2023
years
0.90
lowest link confidence

The story, report by report

Spacing grows with the time between reports.

  1. First warning

    Brenda McWilliams↗

    29 Nov 2019 · Peter Sigee · Manchester (North)

    “I am concerned that the various medical practitioners who attended upon Mrs [name redacted] did not consider continuing prescribing Mrs [name redacted] medication to minimise the risk of VTE after her discharge from hospital on 21st December 2018”
    Original on judiciary.uk ↗

    No published response from National Institute for Health and Care Excellence was found for this report.

  2. 3 years 11 months later

    Raised again · 1st time

    Andrew Nichols↗

    27 Oct 2023 · Nicholas Lane · Worcestershire

    Identical hazardConfidence 0.90 · higha different coroner
    “There seems to be a lack of clarity amongst health and care professionals (certainly those who gave evidence at this inquest) as to whether community organisations receiving patients following discharge from hospital”
    Original on judiciary.uk ↗

    Repeated from the earlier report:dischargehospital

    National Institute for Health and Care Excellence responded, stating 1 specific action.Response (PDF) ↗

    “we propose to review the guideline to see if it can be updated to cover the issue of continuing VTE prophylaxis on discharge so that inpatient anticoagulation prescriptions for VTE prophylaxis are converted to ongoing anticoagulation where required”
  3. All reports to National Institute for Health and Care Excellence

Next

This shows that a similar concern was raised again after an earlier report. It does not say why, and it is not a finding about any organisation or person. To report an error, see the corrections route.

  • Built with
  • NVIDIA Nemotron Nano, Super and Ultra
  • Nebius Token Factory inference
  • Qwen3 Embedding 8B on Token Factory
  • Tavily follow-up web search
  • Postgres and pgvector search
  • Next.js site

Source: Prevention of Future Deaths reports and responses published by the Courts and Tribunals Judiciary at judiciary.uk. Crown copyright, used under the Open Government Licence v3.0. Data updated 26 Oct 2026.

A link shows that a similar concern was raised again, not why. It is not a finding about any organisation or person. Methodology and responsible use · Report an error